Literature DB >> 31825824

Distinct Hepatic PKA and CDK Signaling Pathways Control Activity-Independent Pyruvate Kinase Phosphorylation and Hepatic Glucose Production.

Brandon M Gassaway1, Rebecca L Cardone2, Anil K Padyana3, Max C Petersen4, Evan T Judd3, Sebastian Hayes3, Shuilong Tong5, Karl W Barber1, Maria Apostolidi1, Abudukadier Abulizi2, Joshua B Sheetz6, Hans R Aerni1, Stefan Gross3, Charles Kung3, Varman T Samuel7, Gerald I Shulman4, Richard G Kibbey4, Jesse Rinehart8.   

Abstract

Pyruvate kinase is an important enzyme in glycolysis and a key metabolic control point. We recently observed a pyruvate kinase liver isoform (PKL) phosphorylation site at S113 that correlates with insulin resistance in rats on a 3 day high-fat diet (HFD) and suggests additional control points for PKL activity. However, in contrast to the classical model of PKL regulation, neither authentically phosphorylated PKL at S12 nor S113 alone is sufficient to alter enzyme kinetics or structure. Instead, we show that cyclin-dependent kinases (CDKs) are activated by the HFD and responsible for PKL phosphorylation at position S113 in addition to other targets. These CDKs control PKL nuclear retention, alter cytosolic PKL activity, and ultimately influence glucose production. These results change our view of PKL regulation and highlight a previously unrecognized pathway of hepatic CDK activity and metabolic control points that may be important in insulin resistance and type 2 diabetes.
Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cyclin-dependent kinase; enzyme regulation; hepatic glucose production; insulin resistance; metabolism; nuclear localization; phosphorylation; pyruvate kinase; sub-cellular localization

Mesh:

Substances:

Year:  2019        PMID: 31825824      PMCID: PMC6951436          DOI: 10.1016/j.celrep.2019.11.009

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  77 in total

1.  An iterative statistical approach to the identification of protein phosphorylation motifs from large-scale data sets.

Authors:  Daniel Schwartz; Steven P Gygi
Journal:  Nat Biotechnol       Date:  2005-11       Impact factor: 54.908

2.  Multiplex peptide stable isotope dimethyl labeling for quantitative proteomics.

Authors:  Paul J Boersema; Reinout Raijmakers; Simone Lemeer; Shabaz Mohammed; Albert J R Heck
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

3.  Kinase Substrate Profiling Using a Proteome-wide Serine-Oriented Human Peptide Library.

Authors:  Karl W Barber; Chad J Miller; Jay W Jun; Hua Jane Lou; Benjamin E Turk; Jesse Rinehart
Journal:  Biochemistry       Date:  2018-06-19       Impact factor: 3.162

4.  Pharmacokinetic properties of 2'-O-(2-methoxyethyl)-modified oligonucleotide analogs in rats.

Authors:  R S Geary; T A Watanabe; L Truong; S Freier; E A Lesnik; N B Sioufi; H Sasmor; M Manoharan; A A Levin
Journal:  J Pharmacol Exp Ther       Date:  2001-03       Impact factor: 4.030

5.  Rapid and reproducible single-stage phosphopeptide enrichment of complex peptide mixtures: application to general and phosphotyrosine-specific phosphoproteomics experiments.

Authors:  Arminja N Kettenbach; Scott A Gerber
Journal:  Anal Chem       Date:  2011-09-20       Impact factor: 6.986

6.  Modulation of the phosphorylation state of rat liver pyruvate kinase by allosteric effectors and insulin.

Authors:  T H Claus; M R El-Maghrabi; S J Pilkis
Journal:  J Biol Chem       Date:  1979-08-25       Impact factor: 5.157

7.  SPECHT - single-stage phosphopeptide enrichment and stable-isotope chemical tagging: quantitative phosphoproteomics of insulin action in muscle.

Authors:  Arminja N Kettenbach; Hiroyuki Sano; Susanna R Keller; Gustav E Lienhard; Scott A Gerber
Journal:  J Proteomics       Date:  2014-11-09       Impact factor: 4.044

8.  An ERK/Cdk5 axis controls the diabetogenic actions of PPARγ.

Authors:  Alexander S Banks; Fiona E McAllister; João Paulo G Camporez; Peter-James H Zushin; Michael J Jurczak; Dina Laznik-Bogoslavski; Gerald I Shulman; Steven P Gygi; Bruce M Spiegelman
Journal:  Nature       Date:  2014-11-17       Impact factor: 49.962

9.  Comparative evaluation of electrostatic repulsion-hydrophilic interaction chromatography (ERLIC) and high-pH reversed phase (Hp-RP) chromatography in profiling of rat kidney proteome.

Authors:  Piliang Hao; Yan Ren; Bamaprasad Dutta; Siu Kwan Sze
Journal:  J Proteomics       Date:  2013-02-26       Impact factor: 4.044

10.  iRefIndex: a consolidated protein interaction database with provenance.

Authors:  Sabry Razick; George Magklaras; Ian M Donaldson
Journal:  BMC Bioinformatics       Date:  2008-09-30       Impact factor: 3.169

View more
  2 in total

1.  Targeting Pyruvate Kinase M2 Phosphorylation Reverses Aggressive Cancer Phenotypes.

Authors:  Maria Apostolidi; Ioannis A Vathiotis; Viswanathan Muthusamy; Patricia Gaule; Brandon M Gassaway; David L Rimm; Jesse Rinehart
Journal:  Cancer Res       Date:  2021-06-21       Impact factor: 12.701

2.  Multi-Tissue Acceleration of the Mitochondrial Phosphoenolpyruvate Cycle Improves Whole-Body Metabolic Health.

Authors:  Abudukadier Abulizi; Rebecca L Cardone; Romana Stark; Sophie L Lewandowski; Xiaojian Zhao; Joelle Hillion; Lingjun Ma; Raghav Sehgal; Tiago C Alves; Craig Thomas; Charles Kung; Bei Wang; Stephan Siebel; Zane B Andrews; Graeme F Mason; Jesse Rinehart; Matthew J Merrins; Richard G Kibbey
Journal:  Cell Metab       Date:  2020-11-03       Impact factor: 27.287

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.